Discover
TXMD
TherapeuticsMD, Inc.
2.16
1 x 1.89
1 x 2.52
bid
ask
-
0.05
2.26%
1 @ 04:00 PM
2.13 -0.03 (1.39%)
| Ytd | 32.52% | |
| 1y | 91.15% |
2.15
day range
2.32
0.99
52 week range
2.95
| Open | 2.21 | Prev Close | 2.21 | Low | 2.15 | High | 2.32 | Mkt Cap | 25.00M |
| Vol | 36.07K | Avg Vol | 38.08K | EPS | 0.01 | P/E | 216.00 | Forward P/E | 3.13 |
| Beta | 1.14 | Short Ratio | 0.95 | Inst. Own | 44.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.06 | 200-d Avg | 1.86 | 1yr Est | 5.00 |
| Income Statement | |||
| Total Revenue | 724.00K | ||
| Revenues (USD) | 724.00K | ||
| Gross Profit | 724.00K | ||
| Operating Expenses | 1.45M | ||
| Selling, General and Administrative Expense | 1.35M | ||
| Operating Income | -723.00K | ||
| Net Income | 95.00K | ||
| Net Income Common Stock | 95.00K | ||
| Net Income Common Stock (USD) | 95.00K | ||
| Consolidated Income | 95.00K | ||
| Net Income from Discontinued Operations | 8.00K | ||
| Earnings per Basic Share | 0.01 | ||
| Earnings per Basic Share (USD) | 0.01 | ||
| Earnings per Diluted Share | 0.01 | ||
| Earning Before Interest & Taxes (EBIT) | 95.00K | ||
| Earning Before Interest & Taxes (USD) | 95.00K | ||
| Weighted Average Shares | 11.57M | ||
| Weighted Average Shares Diluted | 11.64M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.42M | ||
| Cash and Equivalents (USD) | 8.42M | ||
| Trade and Non-Trade Receivables | 3.21M | ||
| Current Assets | 15.26M | ||
| Property, Plant & Equipment Net | 5.06M | ||
| Total Assets | 37.58M | ||
| Total Debt | 4.82M | ||
| Current Liabilities | 4.91M | ||
| Debt Non-Current | 4.82M | ||
| Total Liabilities | 10.61M | ||
| Accumulated Retained Earnings (Deficit) | -952.30M | ||
| Shareholders Equity | 26.97M | ||
| Shareholders Equity (USD) | 26.97M | ||
| Assets Non-Current | 22.32M | ||
| Total Debt (USD) | 4.82M | ||
| Goodwill and Intangible Assets | 3.67M | ||
| Liabilities Non-Current | 5.70M | ||
| Trade and Non-Trade Payables | 15.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 325.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 936.00K | ||
| Net Cash Flow from Operations | -8.00K | ||
| Share Based Compensation | 2.00K | ||